Price
415.55
+0.73%52W Range
Market Cap
₹67,356.82 Cr
Traded: ₹92.01 Cr (0.14%) 0.0x
Free Float: ₹15,761.50 Cr (0.58% of FF traded)
Volume · 60D trend
22.25 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Return | +14.0% | +0.0% | +16.0% | +14.0% | -- | Stable |
| ROE | +6.0% | +4.0% | +4.0% | -- | -- | Stable |
| Sales | +18.0% | +19.0% | +15.0% | -- | +11.0% | Decelerating |
| Profit | +1.0% | -12.0% | -15.0% | -- | -61.0% | Decelerating |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,336 | 4,517 | 4,173 | 4,296 | 3,942 | 4,417 | 3,821 | 3,590 | 3,433 | 3,917 | 3,954 | 3,462 | 3,423 | 3,774 | 2,941 | 2,320 |
| Expenses | 3,489 | 3,496 | 3,340 | 3,460 | 3,176 | 3,339 | 3,070 | 2,905 | 2,812 | 3,004 | 3,051 | 2,745 | 2,741 | 2,817 | 2,352 | 1,877 |
| Operating Profit | 847 | 1,020 | 834 | 835 | 766 | 1,078 | 752 | 685 | 620 | 913 | 903 | 717 | 681 | 957 | 589 | 442 |
| OPM % | 20.0% | 23.0% | 20.0% | 19.0% | 19.0% | 24.0% | 20.0% | 19.0% | 18.0% | 23.0% | 23.0% | 21.0% | 20.0% | 25.0% | 20.0% | 19.0% |
| Other Income | 41 | -28 | -176 | 81 | 62 | 57 | 53 | 58 | 1,166 | 40 | 587 | 134 | 94 | 152 | -193 | 48 |
| Interest | 213 | 232 | 210 | 272 | 277 | 212 | 223 | 226 | 236 | 227 | 267 | 248 | 233 | 249 | 120 | 30 |
| Depreciation | 547 | 513 | 515 | 473 | 455 | 436 | 425 | 420 | 405 | 407 | 414 | 389 | 358 | 364 | 301 | 231 |
| Profit Before Tax | 128 | 248 | -68 | 171 | 97 | 487 | 156 | 98 | 1,146 | 319 | 808 | 214 | 184 | 497 | -26 | 229 |
| Tax % | -7.0% | 20.0% | -24.0% | 22.0% | 8.0% | 6.0% | 48.0% | 72.0% | 25.0% | 30.0% | 7.0% | 19.0% | 19.0% | 17.0% | -19.0% | 64.0% |
| Net Profit | 137 | 199 | -52 | 133 | 89 | 459 | 81 | 27 | 862 | 223 | 753 | 173 | 149 | 414 | -21 | 82 |
| Exceptional Items | -- | -80 | -293 | -12 | 0 | 20 | 18 | 26 | 32 | -9 | 21 | -24 | 0 | -3 | -271 | -17 |
| EPS (Rs) | 0.9 | 0.8 | 1.1 | 0.6 | 0.2 | 2.9 | 0.2 | -0.1 | 5.5 | 1.1 | 5.5 | 1.1 | 0.8 | 2.6 | -0.3 | 0.4 |
| Sales Growth (YoY) | 10.0% | 2.3% | 9.2% | 19.6% | 14.8% | 12.8% | -3.4% | 3.7% | 0.3% | 3.8% | 34.4% | 49.3% | 60.0% | -- | -- | -- |
| Sales Growth (QoQ) | -- | 8.2% | -2.9% | 9.0% | -10.8% | 15.6% | 6.4% | 4.6% | -12.4% | -0.9% | 14.2% | 1.1% | -9.3% | 28.3% | 26.8% | -- |
| OP Growth (YoY) | 10.6% | -5.4% | 10.9% | 21.9% | 23.5% | 18.1% | -16.7% | -4.5% | -9.0% | -4.6% | 53.3% | 62.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | -17.0% | 22.3% | -0.1% | 9.0% | -28.9% | 43.4% | 9.8% | 10.5% | -32.1% | 1.1% | 25.9% | 5.3% | -28.8% | 62.5% | 33.3% | -- |
| Profit Growth (YoY) | 328.0% | -62.0% | 1470.0% | 486.0% | -95.0% | 138.0% | -96.0% | -117.0% | 532.0% | -56.0% | 277.0% | 175.0% | -30.0% | 18.0% | -9.0% | -73.0% |
| EPS Growth (YoY) | -- | -72.8% | 414.3% | 584.6% | -95.8% | 154.0% | -96.2% | -112.4% | 553.6% | -56.7% | 1671.4% | 169.2% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -27.8% | 71.4% | 173.9% | -92.0% | 1266.7% | 261.5% | -102.4% | 385.8% | -79.5% | 423.8% | 25.0% | -67.8% | 845.7% | -189.7% | -- |
| OP Margin | -- | 22.6% | 20.0% | 19.4% | 19.0% | 24.4% | 19.7% | 19.1% | 18.1% | 23.3% | 22.8% | 20.7% | 19.9% | 25.4% | 20.0% | 19.1% |
| Net Margin | -- | 4.4% | -1.3% | 3.1% | 2.3% | 10.4% | 2.1% | 0.8% | 25.1% | 5.7% | 19.0% | 5.0% | 4.3% | 11.0% | -0.7% | 3.5% |
| Material Cost % | 33.9% | 31.0% | 32.1% | 36.0% | 35.6% | 33.4% | 35.6% | 32.9% | 34.5% | 33.9% | 31.2% | 32.5% | 35.3% | 32.6% | 33.3% | 32.4% |
| Employee Cost % | 21.1% | 20.2% | 21.0% | 20.7% | 21.1% | 18.4% | 20.6% | 22.0% | 22.0% | 18.9% | 18.2% | 18.0% | 16.9% | 15.1% | 19.0% | 23.3% |
| P/S | 3.89 | 4.07 | 3.68 | 3.83 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 123.68 | 156.32 | 79.47 | 98.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.98 | 2.03 | 2.31 | 2.36 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Company Statement
Earning call Transcript for Q1 FY27
Investor Meet
Voting Results and Scrutinizer''s report
Newspaper Advertisement
Investor Meet
Audio and video recording of Q1 2027
Change in Directorate
Appointment of Statutory Auditors
Change in Directorate
Completion of tenure of Statutory Auditors
Resignation of Statutory auditors of material subsidiaries of the Company.
Proceedings of the 48th AGM of the Company and the Chairperson''s speech.
Outcome of Board Meeting- Financial Results
Outcome of Board Meeting
Completion of tenure of Independent Director
Completion of tenure of Independent Director
Copy of Newspaper Advertisement
Company Statement
Integrated Annual Report for the Financial Year 2025 - 26
Business Responsibility and Sustainability Reporting for the Financial Year 2025 - 26
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mylan Inc.
48th Annual General Meeting for Financial Year 2025 - 26 to be held on Thursday, August 06, 2026
Certificate under Reg 74(5) of SEBI (DP) Regulations
Press Release
Newspaper Publication
Allotment of equity shares on preferential basis
Acquisition of equity shares of Biocon Biologics Limited
Intimation regarding closure of trading window
Intimation regarding closure of trading window
Press Release
Communication to the Shareholders w.r.t TDS on Final Dividend
Acquisition
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
Postal Ballot - Scrutinizer''s Report
Postal Ballot - Outcome
Investor Presentation
Newspaper Advertisement regarding the Corrigendum to the Postal Ballot Notice
Corrigendum to the Postal Ballot Notice dated May 07, 2026
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
Newspaper Publication
Reminder Letter to shareholders to claim unclaimed dividends
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
Transcript of Earnings Call Q4 FY 26
Company Statement
Newspaper Advertisement - Financial Results
Newspaper Advertisement-Postal Ballot Notice
Postal Ballot Notice
Audio and video recording of Q4 2026
Investor Presentation
Annual Reports
15Credit Ratings
6Concalls
73Feb 2026
28 Feb 2026Feb 2026
28 Feb 2026Dec 2025
31 Dec 2025Dec 2025
31 Dec 2025Dec 2025
31 Dec 2025Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jul 2022
31 Jul 2022May 2022
31 May 2022Apr 2022
30 Apr 2022Apr 2022
30 Apr 2022Feb 2022
28 Feb 2022Jan 2022
31 Jan 2022Nov 2021
30 Nov 2021Oct 2021
31 Oct 2021Sep 2021
30 Sept 2021Sep 2021
30 Sept 2021Jul 2021
31 Jul 2021May 2021
31 May 2021Apr 2021
30 Apr 2021Jan 2021
31 Jan 2021Oct 2020
31 Oct 2020Sep 2020
30 Sept 2020Jul 2020
31 Jul 2020Jun 2020
30 Jun 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Dec 2019
31 Dec 2019Dec 2019
31 Dec 2019Oct 2019
31 Oct 2019Sep 2019
30 Sept 2019Sep 2019
30 Sept 2019Jul 2019
31 Jul 2019Jun 2019
30 Jun 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Sep 2018
30 Sept 2018Jun 2018
30 Jun 2018Mar 2018
31 Mar 2018Feb 2018
28 Feb 2018Oct 2017
31 Oct 2017Sep 2017
30 Sept 2017Apr 2017
30 Apr 2017Mar 2017
31 Mar 2017Feb 2017
28 Feb 2017Oct 2016
31 Oct 2016Jul 2016
31 Jul 2016Apr 2016
30 Apr 2016Jan 2016
31 Jan 2016Oct 2015
31 Oct 2015Jul 2015
31 Jul 2015Held by ETFs
29 ETFs hold biocon · sorted by weight
Held by Mutual Funds
113 schemes hold biocon · sorted by weight